Literature DB >> 1754737

Antibiotic pharmacokinetic considerations in pulmonary infections.

B A Cunha1.   

Abstract

The factors affecting the penetration of antibiotics into the respiratory tract and their clinical relevance in treating pulmonary infections are discussed in this article. The importance and interpretation of sputum, bronchial fluid, pleural fluid, and lung tissue levels are emphasized, including a tabular summary of published data on antibiotic levels in the respiratory tract. The relative predictive efficacy of antibiotics against pulmonary pathogens is best expressed by comparing tissue levels with the mean minimum inhibitory concentration of the infecting organism, ie, the "kill ratio." The kill ratio is the best way to compare dissimilar antibiotics in terms of their likely efficacy in treating pulmonary infections, ie, those with high kill ratios (greater than or equal to 2) are more likely to be associated with a favorable clinical outcome than those with lower kill ratios. The difficulties with interpreting pharmacokinetic data from various parts of the respiratory tract in terms of specimen timing, handling, processing, and interpretation are also discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1754737

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  6 in total

Review 1.  Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

2.  Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).

Authors:  C Muller-Serieys; P Soler; C Cantalloube; F Lemaitre; H P Gia; F Brunner; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 3.  Cefpirome clinical pharmacokinetics.

Authors:  L C Strenkoski; D E Nix
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

4.  Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue.

Authors:  Michael Paal; Christina Scharf; Ann Katrin Denninger; Luis Ilia; Charlotte Kloft; Nikolaus Kneidinger; Uwe Liebchen; Sebastian Michel; Christian Schneider; Sebastian Schröpf; Carina Schuster; Michael Vogeser; Ferdinand Weinelt; Johannes Zander; Michael Zoller; Ines Schroeder
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

Review 5.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

Review 6.  Legionnaires' disease: clinical differentiation from typical and other atypical pneumonias.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.